70 related articles for article (PubMed ID: 35804208)
1. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y
Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208
[TBL] [Abstract][Full Text] [Related]
2. Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study.
Paul EN; Satish S; Kelur KK; Shetty MS
Indian J Pathol Microbiol; 2023; 66(3):526-532. PubMed ID: 37530333
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.
Hodgin JB; Mariani LH; Zee J; Liu Q; Smith AR; Eddy S; Hartman J; Hamidi H; Gaut JP; Palmer MB; Nast CC; Chang A; Hewitt S; Gillespie BW; Kretzler M; Holzman LB; Barisoni L;
Am J Kidney Dis; 2022 Jun; 79(6):807-819.e1. PubMed ID: 34864148
[TBL] [Abstract][Full Text] [Related]
4. Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid.
Kawashima N; Naito S; Nagane M; Yamashita T; Nakayama KI
Sci Rep; 2023 Dec; 13(1):22487. PubMed ID: 38110538
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of anti-nephrin antibodies in podocytopaties among adults.
Chebotareva N; Vinogradov A; Birukova Y; Alentov I; Sergeeva N; Chemodanova D; Kononikhin AS; Moiseev SV
Nephrology (Carlton); 2024 Feb; 29(2):86-92. PubMed ID: 37864506
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G deposition on proximal tubules and the tubular basement membrane in acute tubular injury complicated with focal segmental glomerulosclerosis (FSGS): A possible prediction tool for subclinical FSGS.
Kurata S; Nawata A; Morinishi T; Ohta K; Katafuchi E; Hisano S; Tanaka S; Hisaoka M; Koike J; Nishikomori R; Nakayama T
Ann Diagn Pathol; 2023 Oct; 66():152154. PubMed ID: 37216712
[TBL] [Abstract][Full Text] [Related]
7. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
[TBL] [Abstract][Full Text] [Related]
8. Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail?
Vivarelli M; Colucci M
Kidney Int; 2024 Mar; 105(3):440-442. PubMed ID: 38388144
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic Syndrome Gene
Milosavljevic J; Lempicki C; Lang K; Heinkele H; Kampf LL; Leroy C; Chen M; Gerstner L; Spitz D; Wang M; Knob AU; Kayser S; Helmstädter M; Walz G; Pollak MR; Hermle T
J Am Soc Nephrol; 2022 Dec; 33(12):2174-2193. PubMed ID: 36137753
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2.
Hada I; Shimizu A; Takematsu H; Nishibori Y; Kimura T; Fukutomi T; Kudo A; Ito-Nitta N; Kiuchi Z; Patrakka J; Mikami N; Leclerc S; Akimoto Y; Hirayama Y; Mori S; Takano T; Yan K
J Am Soc Nephrol; 2022 Nov; 33(11):2008-2025. PubMed ID: 35985815
[TBL] [Abstract][Full Text] [Related]
11. The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity.
Burke GW; Mitrofanova A; Fontanella A; Ciancio G; Roth D; Ruiz P; Abitbol C; Chandar J; Merscher S; Fornoni A
Front Immunol; 2023; 14():1201619. PubMed ID: 37564655
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults.
Lepori N; Zand L; Sethi S; Fernandez-Juarez G; Fervenza FC
Clin Kidney J; 2018 Apr; 11(2):179-190. PubMed ID: 29644057
[TBL] [Abstract][Full Text] [Related]
13. "Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.
Chugh SS; Clement LC
Am J Physiol Renal Physiol; 2023 Dec; 325(6):F685-F694. PubMed ID: 37795536
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis.
Li Y; Fan J; Zhu W; Niu Y; Wu M; Zhang A
Kidney Dis (Basel); 2023 Aug; 9(4):254-264. PubMed ID: 37900001
[TBL] [Abstract][Full Text] [Related]
15. Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis.
de Zoysa N; Haruhara K; Nikolic-Paterson DJ; Kerr PG; Ling J; Gazzard SE; Puelles VG; Bertram JF; Cullen-McEwen LA
Front Med (Lausanne); 2024; 11():1343161. PubMed ID: 38510448
[TBL] [Abstract][Full Text] [Related]
16. Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.
Barsotti GC; Luciano R; Kumar A; Meliambro K; Kakade V; Tokita J; Naik A; Fu J; Peck E; Pell J; Reghuvaran A; Tanvir EM; Patel P; Zhang W; Li F; Moeckel G; Perincheri S; Cantley L; Moledina DG; Wilson FP; He JC; Menon MC
Kidney Int Rep; 2024 May; 9(5):1354-1368. PubMed ID: 38707807
[TBL] [Abstract][Full Text] [Related]
17. A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS-Like Zebrafish Model.
Schindler M; Siegerist F; Lange T; Simm S; Bach SM; Klawitter M; Gehrig J; Gul S; Endlich N
J Am Soc Nephrol; 2023 Dec; 34(12):1977-1990. PubMed ID: 37752628
[TBL] [Abstract][Full Text] [Related]
18. Is it Time to Re-Evaluate Our Experimental Approach to Studying Diffuse Podocytopathies?
Watts AJB; Weins A
J Am Soc Nephrol; 2022 Nov; 33(11):1959-1960. PubMed ID: 36137754
[No Abstract] [Full Text] [Related]
19. Urine Single-Cell RNA Sequencing in Focal Segmental Glomerulosclerosis Reveals Inflammatory Signatures.
Latt KZ; Heymann J; Jessee JH; Rosenberg AZ; Berthier CC; Arazi A; Eddy S; Yoshida T; Zhao Y; Chen V; Nelson GW; Cam M; Kumar P; Mehta M; Kelly MC; Kretzler M; ; ; Ray PE; Moxey-Mims M; Gorman GH; Lechner BL; Regunathan-Shenk R; Raj DS; Susztak K; Winkler CA; Kopp JB
Kidney Int Rep; 2022 Feb; 7(2):289-304. PubMed ID: 35155868
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species.
Stamellou E; Agrawal S; Siegerist F; Buse M; Kuppe C; Lange T; Buhl EM; Alam J; Strieder T; Boor P; Ostendorf T; Gröne HJ; Floege J; Smoyer WE; Endlich N; Moeller MJ
Nephrol Dial Transplant; 2023 Nov; ():. PubMed ID: 38037533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
